EDGAR Filing Documents for 0001193125-05-049662

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001193125-05-049662

Filing Date

2005-03-14

Accepted

2005-03-14 17:29:49

Documents

Period of Report

2004-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-K	d10k.htm	10-K	1083008
2	AMENDED AND RESTATED 2000 EQUITY INCENTIVE PLAN	dex108.htm	EX-10.8	86590
3	SIXTH AMENDMENT TO LEASE, DATED AS OF DECEMBER 22, 2004	dex1028.htm	EX-10.28	47337
4	CO-PROMOTION AGREEMENT BETWEEN THE COMPANY AND SOLVAY PHARMACEUTICALS, INC.	dex1042.htm	EX-10.42	373493
5	CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM	dex231.htm	EX-23.1	2262
6	CERTIFICATE OF CEO PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002	dex311.htm	EX-31.1	8932
7	CERTIFICATE OF CFO PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002	dex312.htm	EX-31.2	8913
8	CEO CERTIFICATION PURSUANT TO SECTION 906	dex321.htm	EX-32.1	2838
9	CFO CERTICATION PURSUANT TO SECTION 906	dex322.htm	EX-32.2	2807
10	GRAPHIC	g24936img001.jpg	GRAPHIC	301987
11	GRAPHIC	g24936img002.jpg	GRAPHIC	8491
	Complete submission text file	0001193125-05-049662.txt		1929641

Mailing Address 3172 PORTER DRIVE PALO ALTO CA 94304

Business Address 3172 PORTER DR PALO ALTO CA 94304 6503848500

CV THERAPEUTICS INC (Filer) CIK: 0000921506 (see all company filings)